Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients

Diana Hernández; Daniel J Feaster; Lauren Gooden; Antoine Douaihy; Raul Mandler; Sarah J Erickson; Tiffany Kyle; Louise Haynes; Robert Schwartz; Moupali Das; Lisa Metsch

doi:10.1007/s10461-015-1074-2

Back

Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients

Journal article

Open access

Peer reviewed

Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients

Diana Hernández, Daniel J Feaster, Lauren Gooden, Antoine Douaihy, Raul Mandler, Sarah J Erickson, Tiffany Kyle, Louise Haynes, Robert Schwartz, Moupali Das, …

AIDS and behavior, Vol.20(1), pp.204-214

2016-01

DOI: https://doi.org/10.1007/s10461-015-1074-2

PMID: 25952768

Abstract

HIV Seronegativity

Sexual Behavior

Prevalence

Substance Abuse, Intravenous - therapy

Drug Users - statistics & numerical data

HIV Infections - epidemiology

Humans

Middle Aged

Self Report

Substance Abuse, Intravenous - epidemiology

Drug Users - psychology

Mass Screening - statistics & numerical data

Logistic Models

Male

Hepatitis C - diagnosis

HIV Infections - diagnosis

Hepatitis C - epidemiology

HIV Seropositivity - epidemiology

Female

Mass Screening - utilization

Substance Abuse, Intravenous - complications

HIV Seroprevalence

Substance users are at increased risk for HIV and HCV infection. Still, many substance use treatment programs (SUTP) fail to offer HIV/HCV testing. The present secondary analysis of screening data from a multi-site randomized trial of rapid HIV testing examines self-reported HIV/HCV testing patterns and serostatus of 2473 SUTP patients in 12 community-based sites that had not previously offered on-site testing. Results indicate that most respondents screened for the randomized trial tested more than a year prior to intake for HIV (52 %) and HCV (38 %). Prevalence rates were 3.6 and 30 % for HIV and HCV, respectively. The majority of participants that were HIV (52.2 %) and HCV-positive (40.5 %) reported having been diagnosed within the last 1-5 years. Multivariable logistic regression showed that members of high-risk groups were more likely to have tested. Bundled HIV/HCV testing and linkage to care issues are recommended for expanding testing in community-based SUTP settings.

Files and links (1)

url

https://doi.org/10.1007/s10461-015-1074-2View

Published (Version of record) Open

Metrics

20 Record Views

3 Times Cited - Web of Science

See more details

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Industry collaboration; Domestic collaboration
Citation topics: 1 Clinical & Life Sciences; 1.125 Hepatitis; 1.125.83 HCV
Web Of Science research areas: Public, Environmental & Occupational Health; Social Sciences, Biomedical
ESI research areas: Psychiatry/Psychology

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Details

Title: Self-Reported HIV and HCV Screening Rates and Serostatus Among Substance Abuse Treatment Patients
Creators: Diana Hernández - Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, 722 W. 168th St, Rm 934, New York, NY, 10032, USA. dh2494@columbia.edu
Daniel J Feaster - Miller School of Medicine, University of Miami, Miami, FL, USA
Lauren Gooden - Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, 722 W. 168th St, Rm 934, New York, NY, 10032, USA
Antoine Douaihy - University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Raul Mandler - National Institute on Drug Abuse, Bethesda, MD, USA
Sarah J Erickson - Department of Psychology, University of New Mexico, Albuquerque, NM, USA
Tiffany Kyle - The Center for Drug Free Living, Orlando, FL, USA
Louise Haynes - Medical University of South Carolina, Charleston, SC, USA
Robert Schwartz - Friends Research Institute, Baltimore, MD, USA
Moupali Das - School of Medicine, University of California, San Francisco, San Francisco, USA
Lisa Metsch - Department of Sociomedical Sciences, Mailman School of Public Health, Columbia University, 722 W. 168th St, Rm 934, New York, NY, 10032, USA
Publication Details: AIDS and behavior, Vol.20(1), pp.204-214
Publisher: United States
Grant note: U10 DA015833 / NIDA NIH HHS UG1 DA013034 / NIDA NIH HHS HHSN271200522081C / PHS HHS HHSN271200522071C / NIDA NIH HHS RC2 DA028973 / NIDA NIH HHS U10DA13720-09S / NIDA NIH HHS U10 DA013038 / NIDA NIH HHS U10 DA013034 / NIDA NIH HHS U10DA13036 / NIDA NIH HHS U10DA013038 / NIDA NIH HHS U10DA013720 / NIDA NIH HHS U10DA020036 / NIDA NIH HHS UG1 DA013720 / NIDA NIH HHS U10DA13034 / NIDA NIH HHS U10DA13727 / NIDA NIH HHS U10DA15815 / NIDA NIH HHS U10 DA020036 / NIDA NIH HHS U10DA015833 / NIDA NIH HHS HHSN271200522071C / PHS HHS U10 DA013732 / NIDA NIH HHS U10 DA013727 / NIDA NIH HHS U10 DA015815 / NIDA NIH HHS U10 DA013720 / NIDA NIH HHS P30 MH043520 / NIMH NIH HHS U10 DA013036 / NIDA NIH HHS U10DA013732 / NIDA NIH HHS
Academic Unit: Miller School of Medicine; UMMG Department of Public Health Sciences Research
Language: English
Resource Type: Journal article
PMID: 25952768
Record Identifier: 991031560734002976